Revolutionizing Oral Care
Pioneering a new line of therapeutics to reverse the underlying cause of periodontal disease
An Under-Treated Condition
Periodontal disease is one of the most prevalent disease worldwide.
According to the World Health Organization (WHO), over 1 billion people suffer from severe periodontal disease globally. In the United States alone, over 50% of adults suffer from some level of periodontal disease.
Emerging research has also linked periodontal disease with enhanced risk of Alzheimer's, dementia, heart disease, lung disease, poorer COVID outcomes and immune system compromise, and other comorbidities.
The ProEncia Approach
Traditionally, periodontal care has focused on treating isolated disease symptoms, while leaving the underlying condition largely unaddressed.
ProEncia aims to change this. Our unique approach targets the entire disease at all levels of severity and progression, and is underpinned by our team’s deep knowledge of chronic inflammatory diseases and years of groundbreaking pharmaceutical research.
Our goal is to make a treatment that is safer and more effective to alleviate periodontal suffering for millions of people worldwide.
Hear From Patients
ProEncia received feedback from several early users who took part in a clinical case study. Hear their experiences in their own words.